HIGHFDA DRUG

IntegraDose Oxytocin IV Solution Recall 2025 for Subpotent Drug, 853 Bags Nationwide

IntegraDose Compounding Services recalled 853 IV bags of Oxytocin 30 Units/500 mL in 0.9% sodium chloride. The recall is nationwide in the United States. Testing found no oxytocin in the IV bags. Stop using the product and contact IntegraDose or a healthcare provider for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 16, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
September 16, 2025
Hazard Level
HIGH
Brand
IntegraDose Compounding Services
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
PREGNANT, GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
IntegraDose Compounding Services
Product type
IV Oxytocin Solution
Model numbers
Lot #: 20250620OXY-1, Expiration date 10/18/2025
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 16, 2025

  2. Reported by FDA DRUG

    October 22, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact IntegraDose Compounding Services LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

Oxytocin solutions are used in obstetric care to induce or augment labor and to manage postpartum bleeding. This product was produced by a compounding service and distributed nationwide.

Why This Is Dangerous

A subpotent drug means the bag contains insufficient oxytocin to perform its intended therapeutic effect.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

Healthcare facilities may need to switch to alternative oxytocin products and may experience workflow disruptions. No injuries have been reported yet.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 71139-0012-1 on the product label
  2. Check Lot number 20250620OXY-1
  3. Check expiration date 10/18/2025
  4. Confirm packaging indicates Oxytocin 30 Units/500 mL in 0.9% NaCl

Where to find product info

Recall details are posted on the FDA enforcement page for D-0015-2026. Look for the lot and expiration identifiers on each bag.

What timeline to expect

Replacement or disposition typically follows recall processing timelines; 4-8 weeks is a common industry window.

If the manufacturer is unresponsive

  • Document all outreach attempts
  • Escalate to FDA MedWatch with recall details
  • Consult state board of pharmacy or hospital risk management if needed

How to prevent similar issues

  • Source compounded oxytocin only from licensed providers with GMP practices
  • Verify lot number and expiration on every bag
  • Maintain a recall tracking log and verify supplier recalls before use
  • Require confirmation of potency for critical preparations before administration

Documentation advice

Keep the recall notification letter, product labels, lot numbers, and all correspondence with the supplier and health facility.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only Brand: IntegraDose Compounding Services LLC NDC: 71139-0012-1 Lot: 20250620OXY-1 Expiration: 10/18/2025 Quantity: 853 bags Sold/Distributed: Nationwide in the USA Recall Date: 2025-09-16 Status: ACTIVE

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Distribution nationwide in the USA
  • Class I recall (high hazard)

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
PREGNANTGENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot #: 20250620OXY-1
Expiration date 10/18/2025
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more